Real-world Dapagliflozin Experience in Patients With Heart Failure in United Kingdom.

Inclusion Criteria

• •Age ≥18 years as of study index date; the study index date is date of initiation of treatment with dapagliflozin
• •Patient received/receiving treatment with dapagliflozin for HFrEF (EF ≤40%) in accordance with the local dapagliflozin product label
• •Signed and dated informed consent prior to enrolment in the study